Latests BioPartnering
survey results released

We have released the results of our most recent BioPartnering survey, which gives insights into which companies are the most attractive potential partners in the sector and generally most highly regarded by senior executives in the sector.

Key highlights

Current survey results (2017)

The charts show he net positive rating for each company. This is derived by taking the total number of positive answers for each company or factor, subtracting from that the total number of negative answers and expressing that as a percentage of the total ratings for each company.

Previous survey results (2014)

Rankings for individual issues

The following are the top three rankings for issues and functions where the number of datapoints for the issue are above a cut-off point, typically 12.

Having an ethical approach to business and generally

  1. Roche/Genentech
  2. Johnson and Johnson
  3. AstraZeneca

Business development capabilities

  1. Roche/Genentech
  2. Amgen
  3. AstraZeneca

Alliance management capabilities

  1. Roche/Genentech
  2. Amgen
  3. Novartis

Research capabilities

Including clinical research, regulatory and the management of contract research relationships.

  1. Biogen Idec
  2. Johnson and Johnson
  3. Roche/Genentech

Quality of the organisation's leadership

  1. Roche/Genentech
  2. Novartis
  3. Johnson and Johnson

Quality of the organisation's staff and personnel functions

  1. Roche/Genentech
  2. Johnson and Johnson
  3. Novartis

Contact us on contact@BioPartnering.com for more information.